Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Cox Mobile
Spoiler: In order to be eligible for Cox Mobile, customers must already have Cox Internet.
FTC cracks down on food industry for paid dietitian ‘influencer’ posts
Caitlin Gilbert, Sasha Chavkin and Anahad O’Connor, The Washington Post
US regulator cracks down on food industry for paid dietitian ‘influencer’ posts
Sasha Chavkin, Caitlin Gilbert and Anahad O’Connor, The Examination
Evolv Express
FTC investigates marketing of AI weapons scanner.
RevWood Flooring: ‘Wood without Compromise’
Got wood?